Removal of heparan sulfate from the glomerular basement membrane blocks protein passage.

Heparan sulfate (HS) within the glomerular basement membrane (GBM) is thought to play a major role in the charge-selective properties of the glomerular capillary wall. Recent data, however, raise questions regarding the direct role of HS in glomerular filtration. For example, in situ studies suggest that HS may prevent plasma macromolecules from clogging the GBM, keeping it in an "open" state. We evaluated this potential role of HS in vivo by studying the passage of protein through the glomerular capillary wall in the presence and absence of HS. Intravenous administration of neuraminidase removed neuraminic acid--but not HS--from the GBM, and this led to albuminuria. Concomitant removal of HS with heparinase III, confirmed by ultrastructural imaging, prevented the development of albuminuria in response to neuraminidase treatment. Taken together, these results suggest that HS keeps the GBM in an open state, facilitating passage of proteins through the glomerular capillary wall.

[1]  R. Wevers,et al.  In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria. , 2007, Journal of the American Society of Nephrology : JASN.

[2]  R. Goldschmeding,et al.  Increased expression of heparanase in overt diabetic nephropathy. , 2006, Kidney international.

[3]  G. Navis,et al.  Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system. , 2006, Journal of the American Society of Nephrology : JASN.

[4]  Gerard A Ateshian,et al.  Direct measurement of osmotic pressure of glycosaminoglycan solutions by membrane osmometry at room temperature. , 2005, Biophysical journal.

[5]  K. Tryggvason,et al.  How does the kidney filter plasma? , 2005, Physiology.

[6]  T. Weinstein,et al.  Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  G. D'Amico,et al.  Pathophysiology of proteinuria. , 2003, Kidney international.

[8]  B. Olsen,et al.  Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney , 2003, The EMBO journal.

[9]  S. Bowry,et al.  Dialysis membranes today. , 2002, The International journal of artificial organs.

[10]  Bernard Canaud,et al.  Dialysis membranes today , 2002, The International journal of artificial organs.

[11]  R. Linhardt,et al.  Human single chain antibodies against heparin: selection, characterization, and effect on coagulation. , 2002, Blood.

[12]  E. Versteeg,et al.  Large, Tissue-regulated Domain Diversity of Heparan Sulfates Demonstrated by Phage Display Antibodies* , 2002, The Journal of Biological Chemistry.

[13]  J. van den Born,et al.  Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. , 2000, Kidney international.

[14]  A. Groffen,et al.  Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  L. Kjellén,et al.  Regulated Diversity of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.

[16]  A. Groffen,et al.  Differential Expression of Agrin in Renal Basement Membranes As Revealed by Domain-specific Antibodies* , 1998, The Journal of Biological Chemistry.

[17]  R. Hoet,et al.  Generation and Application of Type-specific Anti-Heparan Sulfate Antibodies Using Phage Display Technology , 1998, The Journal of Biological Chemistry.

[18]  M. Ruegg,et al.  Agrin Is a Major Heparan Sulfate Proteoglycan in the Human Glomerular Basement Membrane , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  W. Comper,et al.  A codiffusing system as a novel model for capillary wall charge selectivity. , 1996, Biophysical chemistry.

[20]  M. Bendayan,et al.  High-resolution ultrastructural study of the rat glomerular basement membrane in aminonucleoside nephrosis. , 1996, Ultrastructural pathology.

[21]  E. Vimr,et al.  In vivo enzymatic removal of alpha 2-->6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[22]  J. van den Born,et al.  Presence of N-Unsubstituted Glucosamine Units in Native Heparan Sulfate Revealed by a Monoclonal Antibody (*) , 1995, The Journal of Biological Chemistry.

[23]  L. Heuvel,et al.  Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate , 1995, Diabetologia.

[24]  E. Versteeg,et al.  Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. , 1994, Analytical biochemistry.

[25]  B. S. Daniels,et al.  Increased albumin permeability in vitro following alterations of glomerular charge is mediated by the cells of the filtration barrier. , 1994, The Journal of laboratory and clinical medicine.

[26]  J. Veerkamp,et al.  Application of cationic probes for the ultrastructural localization of proteoglycans in basement membranes , 1994, Microscopy research and technique.

[27]  J. Vienken,et al.  Membranes for dialysis. , 1994, Casopis lekaru ceskych.

[28]  E. Schrama,et al.  Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane , 1994, Diabetologia.

[29]  C. Lambré,et al.  Determination of the sialic acid linkage specificity of sialidases using lectins in a solid phase assay. , 1993, Analytical biochemistry.

[30]  Y. Tsukada,et al.  Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases. , 1993, Clinical nephrology.

[31]  J. van den Born,et al.  Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. , 1993, Kidney international.

[32]  X. Bai,et al.  Developmental changes in heparan sulfate expression: in situ detection with mAbs , 1992, The Journal of cell biology.

[33]  N. Kashihara,et al.  Current status of the structural and functional basis of glomerular filtration and proteinuria. , 1991, Seminars in nephrology.

[34]  W. Deen,et al.  Functional Nature of Glomerular Injury in Progressive Diabetic Glomerulopathy , 1987, Diabetes.

[35]  B. Brenner,et al.  Effect of colloid volume expansion on glomerular barrier size-selectivity in humans. , 1986, Kidney international.

[36]  W. Deen,et al.  Nature of the glomerular capillary injury in human membranous glomerulopathy. , 1986, The Journal of clinical investigation.

[37]  J. Roth,et al.  Localization of sialic acid in kidney glomeruli: regionalization in the podocyte plasma membrane and loss in experimental nephrosis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Yoshida,et al.  A new enzymatic serum creatinine measurement based on an endogenous creatine-eliminating system. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[39]  Y. Kanwar,et al.  Clogging of the glomerular basement membrane , 1982, The Journal of cell biology.

[40]  Y. Kanwar,et al.  Altered glomerular permeability as a result of focal detachment of the visceral epithelium. , 1982, Kidney international.

[41]  M. Farquhar,et al.  Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion , 1980, The Journal of cell biology.

[42]  M. Farquhar,et al.  Assembly of the glomerular filtration surface. Differentiation of anionic sites in glomerular capillaries of newborn rat kidney , 1980, The Journal of cell biology.

[43]  H. Gregor,et al.  Synthetic-Membrane Technology , 1978 .

[44]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[45]  L. V. D. Heuvel,et al.  The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type , 2004, Pediatric Nephrology.

[46]  J. Rapola,et al.  Glomerular anionic charge in congenital nephrotic syndrome of the Finnish type , 2004, The Histochemical Journal.

[47]  S. Selleck,et al.  Order out of chaos: assembly of ligand binding sites in heparan sulfate. , 2002, Annual review of biochemistry.

[48]  T. Aizawa,et al.  Loss of glomerular anionic sites and the development of albuminuria in rats with streptozotocin-induced diabetes. , 1993, Nephron.

[49]  H. Makino,et al.  Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy. , 1992, Nephron.

[50]  J. van den Born,et al.  A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. , 1992, Kidney international.